H-group (homology)
4246.1 N-terminal domain in RNA-polymerase beta-prime subunit
Ligands and drugs
2,284
Member domains
1,107
with ligand contacts (≤ 4 Å)
48.5% of members
460
with DrugDomain annotations
20.1% of members
15
with a DrugBank compound
0.7% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 4246.1 belongs to X-group 4246 N-terminal domain in RNA-polymerase beta-prime subunit, which binds 6.5 ligand superclasses per 20 proteins, narrower than 68% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB00156 | THR | Threonine | 2 |
| DB00160 | ALA | Alanine | 2 |
| DB08226 | MXP | Myxopyronin B | 2 |
| DB00131 | AMP | Adenosine phosphate | 1 |
| DB00171 | ATP | ATP | 1 |
| DB03170 | COD | Dephospho Coenzyme A | 1 |
| DB04457 | DG | 2'-Deoxyguanosine-5'-Monophosphate | 1 |
| DB08266 | NE6 | Methyl [(1E,5R)-5-{3-[(2E,4E)-2,5-dimethyl-2,4-octadienoyl]-2,4-dioxo-3,4-dihydro-2H-pyran-6-yl}hexylidene]carbamate | 1 |
| DB08874 | FI8 | Fidaxomicin | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| ZNmetal | ZINC ION | 1,100 |
| 1N7 | CHAPSO | 20 |
| MGmetal | MAGNESIUM ION | 7 |
| C5P | CYTIDINE-5'-MONOPHOSPHATE | 6 |
| 2TM | 5'-O-[(S)-hydroxy{[(S)-hydroxy(phosphonooxy)phosphoryl]methyl}phosphoryl]cytidine | 4 |
| FI8 | Fidaxomicin | 4 |
| 4QM | (3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-10,13-dimethyl-17-[(2R)-pentan-2-yl]-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthrene-3,7,12-triol | 3 |
| 4C2 | N-[3,4-dioxo-2-(4-{[4-(trifluoromethyl)benzyl]amino}piperidin-1-yl)cyclobut-1-en-1-yl]-3,5-dimethyl-1,2-oxazole-4-sulfonamide | 2 |
| 4C6 | 3,5-dimethyl-N-{2-[4-(4-methylbenzyl)piperidin-1-yl]-3,4-dioxocyclobut-1-en-1-yl}-1,2-oxazole-4-sulfonamide | 2 |
| A1IF9 | [[(2~{R},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-oxidanyl-phosphoryl] [[[(2~{R},3~{S},4~{R},5~{R})-5-(2-azanyl-6-oxidanylidene-1~{H}-purin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-oxidanyl-phosphoryl]oxy-oxidanyl-phosphoryl] hydrogen phosphate | 2 |
| B4P | BIS(ADENOSINE)-5'-TETRAPHOSPHATE | 2 |
| C0L | methyl[(1E,5R)-5-{(3E)-3-[(2E,4E,8R,9E,12E)-1,8-dihydroxy-2,5,9-trimethyltetradeca-2,4,9,12-tetraen-1-ylidene]-2,4-dioxo-3,4-dihydro-2H-pyran-6-yl}hex-1-en-1-yl]carbamate | 2 |
| MXP | Myxopyronin B | 2 |
| PBmetal | LEAD (II) ION | 2 |
| 4C4 | Myxopyronin B | 1 |
| A1L89 | P1-(5'-Adenosyl) P4-(5'-uridyl) tetraphosphate | 1 |
| A1L9G | P1-(5'-Adenosyl) P4-(5'-guanosyl) tetraphosphate | 1 |
| CTP | CYTIDINE-5'-TRIPHOSPHATE | 1 |
| DGP | 2'-DEOXYGUANOSINE-5'-MONOPHOSPHATE | 1 |
| G2P | PHOSPHOMETHYLPHOSPHONIC ACID GUANYLATE ESTER | 1 |